Bengt Mannervik
From Wikipedia, the free encyclopedia
19 August 1943
Bengt Mannervik | |
|---|---|
| Born | Bengt Eriksson 19 August 1943 Stockholm, Sweden |
| Education | Norra Real, Stockholm, Stockholm University (Ph.D. 1969) |
| Known for | Studies of enzymes involved in glutathione metabolism |
| Awards | Björkén Prize (Uppsala University) |
| Scientific career | |
| Fields | Biochemistry |
| Institutions | Stockholm University, Uppsala University, Scripps Research Institute, La Jolla, California, and many visiting appointments |
Bengt Mannervik (born 19 August 1943 in Stockholm),[1] is a Swedish biochemist known especially for work on enzymes related to glutathione metabolism.
After secondary education under his birth name, Bengt Eriksson, at Norra Real in Stockholm, Bengt Mannervik studied at Stockholm University[1] where he obtained his Licentiate of Philosophy in chemistry with a thesis on biochemistry in 1967. He obtained a Ph.D. there in 1969, and became a Docent (associate professor) at Stockholm University in 1970.
Career
Bengt Mannervik was Senior Lecturer in the Department of Biochemistry at Stockholm University from 1970 to 1987, and was Acting Chairman for numerous periods between 1971 and 1988.[2] In 1988 he moved to Uppsala University as holder of the Karin and Herbert Jacobsson endowed chair in biochemistry.[1] He was Chairman of the Biochemistry Department from 1998 to 2000. From 2010 to 2012 he was a Senior Professor at Uppsala University, and was a member of the university senate from 2005 to 2008.[2]
In 2010 he became Professor at Stockholm University.[1][3] In addition he was an adjunct professor at the Scripps Research Institute in La Jolla, California, between 2013 and 2025.[2]
Visiting professorships
He has had visiting professorships at UC Berkeley; University of Chieti, Italy; University of Perugia, Italy; the Scripps Research Institute, La Jolla, California; and the Collège de France, Paris[2]
Professional services
He has fulfilled roles in numerous professional organizations, including the Swedish Biochemical Society (secretary 1976–1982); Chairman of the Swedish National Committee on Biochemistry, Royal Swedish Academy of Sciences, 1988–1990; Chairman Scientific Program Committee for the 22nd Meeting of the Federation of European Biochemical Societies, FEBS 1993; editorial boards of the Biochemical Journal, ChemBioChem, Biochimica et Biophysica Acta, Protein Engineering Design and Selection, the Journal of Biological Chemistry.
In addition, he has had advisory roles at various companies: Telik Inc.; PanVera Corporation, Pharmacia Biotech; Uniroyal Chemical Company; Biovitrum AB; Maxygen; Vividion; Oxford Biomedical Research, Rochester Hills, Michigan.